Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
What is Cancer?02:12

What is Cancer?

10.6K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.6K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
Cancer Survival Analysis01:21

Cancer Survival Analysis

334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Women's Fear and Risk Factors: Predicting Coercive Control From Police Domestic Violence Supplementary Forms.

Violence against women·2026
Same author

Stat Bite: Cancer risk factors in the US in 2024; obesity, BMI ≥ 30 in people over 20 years.

Journal of the National Cancer Institute·2026
Same author

Multi-arm multi-stage platform trials for neurological disease: accelerating progress.

Lancet (London, England)·2026
Same author

plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis-Derived Variants in Liquid Biopsies from Patients with Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Stat Bite: A reversal of esophageal cancer mortality between non-Hispanic Black and White individuals in the United States.

Journal of the National Cancer Institute·2026
Same author

Stat Bite: Recent trends in ovarian cancer among Non-Hispanic Black and Non-Hispanic White women.

Journal of the National Cancer Institute·2026
Same journal

Impact of WHO Classification of Tumours on cancer prevention, diagnosis, research, public health, and economics.

Journal of the National Cancer Institute. Monographs·2026
Same journal

Cancer epigenetics: unraveling etiology and mechanisms to advance prevention.

Journal of the National Cancer Institute. Monographs·2026
Same journal

Oncogenic infections: targets highly amenable to cancer prevention.

Journal of the National Cancer Institute. Monographs·2026
Same journal

The continuing importance of the IARC's international remit in cancer research.

Journal of the National Cancer Institute. Monographs·2026
Same journal

Environmental and occupational cancer: highlighting research contributions from the IARC on its 60th anniversary.

Journal of the National Cancer Institute. Monographs·2026
Same journal

Progress in identifying the preventable causes of human cancer: the experience of the IARC Monographs program.

Journal of the National Cancer Institute. Monographs·2026
See all related articles

Related Experiment Video

Updated: Jun 17, 2025

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
08:26

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer

Published on: March 24, 2013

24.9K

The SEER Program's longstanding commitment to making cancer resources available.

Patricia K Murphy1, Mark E Sellers1, Sarah H Bonds1

  • 1Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.

Journal of the National Cancer Institute. Monographs
|August 5, 2024
PubMed
Summary
This summary is machine-generated.

The Surveillance, Epidemiology, and End Results (SEER) Program provides vital US cancer statistics and resources. It serves diverse audiences including researchers and the public, enhancing cancer research and awareness.

More Related Videos

Preparation and Metabolic Assay of 3-dimensional Spheroid Co-cultures of Pancreatic Cancer Cells and Fibroblasts
10:51

Preparation and Metabolic Assay of 3-dimensional Spheroid Co-cultures of Pancreatic Cancer Cells and Fibroblasts

Published on: August 23, 2017

12.3K
Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

15.8K

Related Experiment Videos

Last Updated: Jun 17, 2025

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
08:26

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer

Published on: March 24, 2013

24.9K
Preparation and Metabolic Assay of 3-dimensional Spheroid Co-cultures of Pancreatic Cancer Cells and Fibroblasts
10:51

Preparation and Metabolic Assay of 3-dimensional Spheroid Co-cultures of Pancreatic Cancer Cells and Fibroblasts

Published on: August 23, 2017

12.3K
Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

15.8K

Area of Science:

  • Oncology
  • Public Health
  • Biostatistics

Background:

  • The Surveillance, Epidemiology, and End Results (SEER) Program, funded by the National Cancer Institute (NCI) since 1973, is a primary source for US cancer statistics.
  • SEER aims to measure the national cancer burden, disseminate findings, and support cancer research initiatives.

Purpose of the Study:

  • To outline the SEER Program's objectives and the diverse resources it offers to various user groups.
  • To highlight SEER's commitment to accessibility, user experience, and continuous resource updates in line with legislative mandates.

Main Methods:

  • The SEER Program collects and analyzes cancer data across the United States.
  • Resources are developed and maintained for specific audiences: cancer registrars, researchers, and the general public.

Main Results:

  • SEER provides specialized resources like SEER*Rx, SEER*DMS, SEER*Stat, and linked databases (e.g., SEER-Medicare).
  • Public-facing materials include Cancer Stat Facts sheets, SEER*Explorer, and educational video series.
  • Resources are updated to comply with legislation like the Plain Writing Act and 21st Century Integrated Digital Experience Act (IDEA).

Conclusions:

  • The SEER Program's dedication to providing accessible and understandable cancer data is crucial for research, public health, and informed decision-making.
  • Ongoing efforts focus on promoting SEER resources, ensuring broad accessibility, and standardizing the dissemination of new information.